(Q35280688)

7 August 2017

title

Pregnancy outcomes following maternal and paternal exposure to teriflunomide during treatment for relapsing-remitting multiple sclerosis (English)

1 reference

7 August 2017

0 references

1

Bernd C Kieseier

1 reference

7 August 2017

Myriam Benamor

2

1 reference

7 August 2017

publication date

20 November 2014

1 reference

7 August 2017

published in

Neurology and therapy

1 reference

7 August 2017

volume

3

1 reference

7 August 2017

issue

2

1 reference

7 August 2017

page(s)

133-138

1 reference

Pregnancy outcomes in the clinical development program of fingolimod in multiple sclerosis

7 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4386431

Teriflunomide in relapsing multiple sclerosis: therapeutic utility

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4386431

Update on reproductive safety of current and emerging disease-modifying therapies for multiple sclerosis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4386431

Multiple sclerosis and pregnancy: therapeutic considerations

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4386431

Birth outcomes in women who have taken leflunomide during pregnancy

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4386431

Multiple sclerosis and pregnancy.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4386431

Risk factors in miscarriage: a review

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4386431

Pregnancy outcome in women exposed to leflunomide before or during pregnancy

12 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS40120-014-0020-Y

Randomized trial of oral teriflunomide for relapsing multiple sclerosis.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS40120-014-0020-Y

Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS40120-014-0020-Y

10.1007/S40120-014-0020-Y

21 January 2018

Identifiers

DOI

1 reference

7 August 2017

1 reference

7 August 2017

1 reference